Versant Venture Capital V (Canada), LP is 10% Owner at CRISPR Therapeutics AG (CRSP). They have made 1 open-market trade across 1 company since 2016, most recently 2021-06-01.
CIK 0001612235
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $8K since 2016, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CRSP | BUY | 2016-10-24 | 2016-12-23 | $14.00 | $8K | +4.4% | -14.1% | -17.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.